Alicia A. Whittlesey


Share with:


Alicia Whittlesey is a member of the firm’s Life Sciences Compliance and Regulatory Counseling Department. She focuses her practice on advising clients on the laws and enforcement measures governing the life sciences industry including HIPAA, Anti-Kickback legislation, PhRMA Code, Food, Drug & Cosmetics Act, and FDA guidance and regulations surrounding the compliant advertising and promotion of pharmaceutical products, as well as compliant medical activities.

Ms. Whittlesey has experience analyzing and managing legal and commercial risks from a US and global perspective. With over 15 years of experience working as in-house legal and compliance for multiple companies in the life sciences industry, Ms. Whittlesey leverages her background by providing a valued business perspective guiding teams and stakeholders.

Ms. Whittlesey is also Vice President of Compliance Services for Porzio Life Sciences, the firm's wholly owned subsidiary. She collaborates with companies to provide regulatory and compliance guidance on programs, policies and procedures that govern the life sciences industry.

Speaking Engagements

  • "Closing Remarks," Porzio's Ethics & Eggs 2021, 12/09/2021
  • "Enforcement Action Current Trends: Compliance Takeaways from the Incyte Complaint," Porzio Life Sciences Webinar, 6/30/2021
  • "Compliant Patient Interactions," CBI's 16th Annual Pharmaceutical Compliance Congress, 4/18/2019

Prior Relevant Experience

  • Biogen, Weston, MA, Commercial Counsel Legal Affairs, 2013-2018
  • Sunovion Pharmaceuticals Inc. (formerly sepracor Inc.), Marlborough, MA, Counsel, 2008-2010; Senior CounselCommercial Legal Affairs, 2010-2012
  • Bristol-Myers Squibb Company, Plainsboro, NJ, Associate Counsel, 2005-2008
  • Eisai Inc, Teaneck, NJ, Administrative AssistantParalegal, 1996-2002; Counsel, 2002-2005